Continuous Positive Airway Pressure Reduces Plasma Neurochemical Levels in Patients with OSA: A Pilot Study

Continuous Positive Airway Pressure Reduces Plasma Neurochemical Levels in Patients with OSA: A Pilot Study

Obstructive sleep apnea (OSA) is a risk factor for neurodegenerative diseases. This study determined whether continuous positive airway pressure (CPAP), which can alleviate OSA symptoms, can reduce neurochemical biomarker levels. Thirty patients with OSA and normal cognitive function were recruited...

Full description

Bibliographic Details
Main Authors: Wen-Te Liu, Huei-Tyng Huang, Hsin-Yi Hung, Shang-Yang Lin, Wen-Hua Hsu, Fang-Yu Lee, Yi-Chun Kuan, Yin-Tzu Lin, Chia-Rung Hsu, Marc Stettler, Chien-Ming Yang, Jieni Wang, Ping-Jung Duh, Kang-Yun Lee, Dean Wu, Hsin-Chien Lee, Jiunn-Horng Kang, Szu-Szu Lee, Hsiu-Jui Wong, Cheng-Yu Tsai, Arnab Majumdar
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Life
Subjects:
obstructive sleep apnea (OSA)
neurodegenerative diseases
continuous positive airway pressure (CPAP)
total tau (T-Tau)
amyloid beta-peptide 42 (Aβ<sub>42</sub>)
Online Access:https://www.mdpi.com/2075-1729/13/3/613

Internet

https://www.mdpi.com/2075-1729/13/3/613

Similar Items